Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver.

To characterize the coordinate regulation of cholesterol metabolism in human liver, we simultaneously quantified mRNA levels of cholesterol 7alpha-hydroxylase (CYP7A1), 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR), and low- density lipoprotein receptors (LDLRs) in liver biopsies from 76 patients undergoing cholecystectomy. The three transcript levels were not different between untreated gallstone and gallstone-free patients and not significantly altered by 10-d exclusion of dietary cholesterol. Treatment with chenodeoxycholic acid suppressed CYP7A1 and to a lesser extent HMGR mRNA levels. Cholestyramine treatment increased CYP7A1, but also HMGR and LDLR mRNA, and statins only increased HMGR mRNA. Resin + statin treatment increased all mRNA species. In untreated patients, the mRNA levels of HMGR and LDLR were more strongly correlated (r = +0.60) than those of CYP7A1 and HMGR (r = +0.49) or CYP7A1 and LDLR (r = +0.21). In the treated patients, in whom bile acid synthesis was suppressed or stimulated, mRNA levels of CYP7A1 and HMGR (r = +0.84) as well as CYP7A1 and LDLR (r = +0.62) were more strongly correlated than those of HMGR and LDLR (r = +0.59). The coordinate control of HMGR and LDLR mRNA levels reflects their common regulation by shared transcriptional activation. In contrast, following changes in bile acid flux through the liver, CYP7A1 gene expression becomes a strong modulator of hepatic cholesterol metabolism.

[1]  B. Angelin,et al.  Differences in the Regulation of the Classical and the Alternative Pathway for Bile Acid Synthesis in Human Liver , 2002, The Journal of Biological Chemistry.

[2]  D. Russell,et al.  Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. , 2001, Journal of lipid research.

[3]  B. Nyberg,et al.  Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol
7α‐hydroxylase activity , 1999, Journal of internal medicine.

[4]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Eriksson,et al.  Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? , 1999, Current opinion in lipidology.

[6]  D. Russell,et al.  Nuclear Orphan Receptors Control Cholesterol Catabolism , 1999, Cell.

[7]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[8]  H. Princen,et al.  Regulation of Bile Acid Biosynthesis , 1997, Current Pharmaceutical Design.

[9]  R. Hammer,et al.  Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. , 1998, The Journal of clinical investigation.

[10]  S. Grundy,et al.  Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. , 1998, The Journal of clinical investigation.

[11]  K. Einarsson,et al.  Hepatic cholesterol metabolism in human obesity , 1997, Hepatology.

[12]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[13]  Y. Matsuzawa,et al.  Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol. , 1996, Gastroenterology.

[14]  G. Levine,et al.  Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. , 1995, The New England journal of medicine.

[15]  E. Powell,et al.  Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. , 1994, The Journal of clinical investigation.

[16]  J. Dietschy,et al.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. , 1993, Journal of lipid research.

[17]  M. Noshiro,et al.  Structure of the gene encoding human liver cholesterol 7α-hydroxylase , 1993 .

[18]  P. Lievens,et al.  Protein-DNA interactions in the 5'-flanking region of the bovine pancreatic ribonuclease gene. , 1992, Biochimica et biophysica acta.

[19]  S. Sahlin,et al.  Cholesterol metabolism in human gallbladder mucosa: Relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment , 1992, Hepatology.

[20]  J. Gustafsson,et al.  Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Rudling.  Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. , 1992, Journal of lipid research.

[22]  K. Einarsson,et al.  Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. , 1991, Gastroenterology.

[23]  P. Hylemon,et al.  Regulation of bile acid synthesis , 1991, Hepatology.

[24]  K. Einarsson,et al.  Hepatic cholesterol metabolism in cholesterol gallstone disease. , 1991, Journal of lipid research.

[25]  M. Eriksson,et al.  Influence of age on the metabolism of plasma low density lipoproteins in healthy males. , 1991, The Journal of clinical investigation.

[26]  K. Einarsson,et al.  Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. , 1990, Journal of lipid research.

[27]  T. Friedmann,et al.  Post-transcriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity. , 1990, Journal of lipid research.

[28]  K. Einarsson,et al.  Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. , 1990, The New England journal of medicine.

[29]  N. Myant.  Cholesterol Metabolism, LDL, and the LDL Receptor , 1990 .

[30]  K. Einarsson,et al.  Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. , 1989, Gastroenterology.

[31]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[32]  K. Einarsson,et al.  Bile acid synthesis in man: assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by isotope dilution-mass spectrometry. , 1986, Journal of lipid research.

[33]  B. Stevens,et al.  Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. , 1985, The Journal of biological chemistry.

[34]  K. Einarsson,et al.  Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. , 1985, The New England journal of medicine.

[35]  R. Heller,et al.  3-hydroxy-3-methylglutaryl coenzyme A reductase in human liver microsomes: active and inactive forms and cross-reactivity with antibody against rat liver enzyme. , 1984, Journal of lipid research.

[36]  D. Russell,et al.  The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.

[37]  J. Ahlberg,et al.  Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. , 1981, Journal of lipid research.

[38]  H. Ellis,et al.  Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids* , 1980, European journal of clinical investigation.

[39]  A. Smerieri,et al.  Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid. , 1980, Journal of lipid research.

[40]  S. Grundy,et al.  Risk factors for the development of cholelithiasis in man (second of two parts). , 1978, The New England journal of medicine.

[41]  G. Bonorris,et al.  Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. , 1976, The Journal of laboratory and clinical medicine.

[42]  S. Shefer,et al.  Hepatic cholesterol metabolism in patients with gallstones. , 1975, Gastroenterology.